1 |
Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65.
DOI
|
2 |
Lee J, Lee JH, Kim JA, Rhee CK. Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis 2017;12:27-33.
|
3 |
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
DOI
|
4 |
Lee JY, Rhee CK, Jung KS, Yoo KH. Strategies for management of the early chronic obstructive lung disease. Tuberc Respir Dis 2016;79:121-6.
DOI
|
5 |
Organisation for Economic Co-operation and Development. Health at a glance 2015: OECD indicators. Paris: OECD; 2015.
|
6 |
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 2017;49:1700214.
DOI
|
7 |
Health Insurance Review & Assessment Service. Evaluation of appropriate management of COPD in Korea 2017 [Internet]. Wonju: Health Insurance Review & Assessment Service; 2017 [cited 2017 May 1]. Available from: http://www.hira.or.kr/re/diag/getDiagEvlList.do?pgmid=HIRAA030004000000&WT. ac=%EB%B3%91%EC%9B%90%ED%8F%89%EA%B0%80.
|
8 |
Beeh KM. The role of bronchodilators in preventing exacerbations of chronic obstructive pulmonary disease. Tuberc Respir Dis 2016;79:241-7.
DOI
|